152 related articles for article (PubMed ID: 35804015)
1. DNMT1-mediated epigenetic silencing of TRAF6 promotes prostate cancer tumorigenesis and metastasis by enhancing EZH2 stability.
Li Z; Li B; Yu H; Wang P; Wang W; Hou P; Li M; Chu S; Zheng J; Mao L; Bai J
Oncogene; 2022 Aug; 41(33):3991-4002. PubMed ID: 35804015
[TBL] [Abstract][Full Text] [Related]
2. HOTAIR-mediated reciprocal regulation of EZH2 and DNMT1 contribute to polyphyllin I-inhibited growth of castration-resistant prostate cancer cells in vitro and in vivo.
Xiang S; Zou P; Tang Q; Zheng F; Wu J; Chen Z; Hann SS
Biochim Biophys Acta Gen Subj; 2018 Mar; 1862(3):589-599. PubMed ID: 29221985
[TBL] [Abstract][Full Text] [Related]
3. DNMT1 recruited by EZH2-mediated silencing of miR-484 contributes to the malignancy of cervical cancer cells through MMP14 and HNF1A.
Hu Y; Wu F; Liu Y; Zhao Q; Tang H
Clin Epigenetics; 2019 Dec; 11(1):186. PubMed ID: 31810492
[TBL] [Abstract][Full Text] [Related]
4. SKP2 loss destabilizes EZH2 by promoting TRAF6-mediated ubiquitination to suppress prostate cancer.
Lu W; Liu S; Li B; Xie Y; Izban MG; Ballard BR; Sathyanarayana SA; Adunyah SE; Matusik RJ; Chen Z
Oncogene; 2017 Mar; 36(10):1364-1373. PubMed ID: 27869166
[TBL] [Abstract][Full Text] [Related]
5. The EZH2- H3K27me3-DNMT1 complex orchestrates epigenetic silencing of the wwc1 gene, a Hippo/YAP pathway upstream effector, in breast cancer epithelial cells.
Liu X; Li C; Zhang R; Xiao W; Niu X; Ye X; Li Z; Guo Y; Tan J; Li Y
Cell Signal; 2018 Nov; 51():243-256. PubMed ID: 30121333
[TBL] [Abstract][Full Text] [Related]
6. Expression changes in EZH2, but not in BMI-1, SIRT1, DNMT1 or DNMT3B are associated with DNA methylation changes in prostate cancer.
Hoffmann MJ; Engers R; Florl AR; Otte AP; Muller M; Schulz WA
Cancer Biol Ther; 2007 Sep; 6(9):1403-12. PubMed ID: 18637271
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of EZH2 via activation of SAPK/JNK and reduction of p65 and DNMT1 as a novel mechanism in inhibition of human lung cancer cells by polyphyllin I.
Li L; Wu J; Zheng F; Tang Q; Wu W; Hann SS
J Exp Clin Cancer Res; 2016 Jul; 35(1):112. PubMed ID: 27421653
[TBL] [Abstract][Full Text] [Related]
8. Combating castration-resistant prostate cancer by co-targeting the epigenetic regulators EZH2 and HDAC.
Schade AE; Kuzmickas R; Rodriguez CL; Mattioli K; Enos M; Gardner A; Cichowski K
PLoS Biol; 2023 Apr; 21(4):e3002038. PubMed ID: 37104245
[TBL] [Abstract][Full Text] [Related]
9. DNMT1 and EZH2 mediated methylation silences the microRNA-200b/a/429 gene and promotes tumor progression.
Ning X; Shi Z; Liu X; Zhang A; Han L; Jiang K; Kang C; Zhang Q
Cancer Lett; 2015 Apr; 359(2):198-205. PubMed ID: 25595591
[TBL] [Abstract][Full Text] [Related]
10. EZH2 dependent H3K27me3 is involved in epigenetic silencing of ID4 in prostate cancer.
Chinaranagari S; Sharma P; Chaudhary J
Oncotarget; 2014 Aug; 5(16):7172-82. PubMed ID: 25115397
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic Reprogramming with Antisense Oligonucleotides Enhances the Effectiveness of Androgen Receptor Inhibition in Castration-Resistant Prostate Cancer.
Xiao L; Tien JC; Vo J; Tan M; Parolia A; Zhang Y; Wang L; Qiao Y; Shukla S; Wang X; Zheng H; Su F; Jing X; Luo E; Delekta A; Juckette KM; Xu A; Cao X; Alva AS; Kim Y; MacLeod AR; Chinnaiyan AM
Cancer Res; 2018 Oct; 78(20):5731-5740. PubMed ID: 30135193
[TBL] [Abstract][Full Text] [Related]
12. DNMT1 modulates interneuron morphology by regulating Pak6 expression through crosstalk with histone modifications.
Symmank J; Bayer C; Schmidt C; Hahn A; Pensold D; Zimmer-Bensch G
Epigenetics; 2018; 13(5):536-556. PubMed ID: 29912614
[TBL] [Abstract][Full Text] [Related]
13. Histone Methyltransferase Enhancer of Zeste Homolog 2-Mediated ABCA1 Promoter DNA Methylation Contributes to the Progression of Atherosclerosis.
Lv YC; Tang YY; Zhang P; Wan W; Yao F; He PP; Xie W; Mo ZC; Shi JF; Wu JF; Peng J; Liu D; Cayabyab FS; Zheng XL; Tang XY; Ouyang XP; Tang CK
PLoS One; 2016; 11(6):e0157265. PubMed ID: 27295295
[TBL] [Abstract][Full Text] [Related]
14. DNMT1-mediated epigenetic suppression of FBXO32 expression promoting cyclin dependent kinase 9 (CDK9) survival and esophageal cancer cell growth.
Song XQ; Chen BB; Jin YM; Wang CY
Cell Cycle; 2024 Feb; 23(3):262-278. PubMed ID: 38597826
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of enhancer of zeste homolog 2 (EZH2) overcomes enzalutamide resistance in castration-resistant prostate cancer.
Bai Y; Zhang Z; Cheng L; Wang R; Chen X; Kong Y; Feng F; Ahmad N; Li L; Liu X
J Biol Chem; 2019 Jun; 294(25):9911-9923. PubMed ID: 31085587
[TBL] [Abstract][Full Text] [Related]
16. LncRNA LINC00673 inhibits p53 expression by interacting with EZH2 and DNMT1 in papillary thyroid carcinoma.
Meng XF; Zhao LY; Chu XF
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2075-2083. PubMed ID: 30915752
[TBL] [Abstract][Full Text] [Related]
17. EPHA3 Contributes to Epigenetic Suppression of PTEN in Radioresistant Head and Neck Cancer.
Kim SH; Kang BC; Seong D; Lee WH; An JH; Je HU; Cha HJ; Chang HW; Kim SY; Kim SW; Han MW
Biomolecules; 2021 Apr; 11(4):. PubMed ID: 33919657
[TBL] [Abstract][Full Text] [Related]
18. Cooperation between EZH2, NSPc1-mediated histone H2A ubiquitination and Dnmt1 in HOX gene silencing.
Wu X; Gong Y; Yue J; Qiang B; Yuan J; Peng X
Nucleic Acids Res; 2008 Jun; 36(11):3590-9. PubMed ID: 18460542
[TBL] [Abstract][Full Text] [Related]
19. Interplay of DNA methyltransferase 1 and EZH2 through inactivation of Stat3 contributes to β-elemene-inhibited growth of nasopharyngeal carcinoma cells.
Wu J; Tang Q; Yang L; Chen Y; Zheng F; Hann SS
Sci Rep; 2017 Mar; 7(1):509. PubMed ID: 28360411
[TBL] [Abstract][Full Text] [Related]
20. The frequency of CpG and non-CpG methylation of Notch3 gene promoter determines its expression levels in breast cancer cells.
Xiao W; Liu X; Niu X; Li C; Guo Y; Tan J; Xiong W; Fan L; Li Y
Exp Cell Res; 2020 Jan; 386(2):111743. PubMed ID: 31770532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
